57 223

Cited 20 times in

Inhibition of Pim1 kinase activation attenuates allergen-induced airway hyperresponsiveness and inflammation

Authors
Shin, YS; Takeda, K; Shiraishi, Y; Jia, Y; Wang, M; Jackson, L; Wright, AD; Carter, L; Robinson, J; Hicken, E; Gelfand, EW
Citation
American journal of respiratory cell and molecular biology, 46(4):488-497, 2012
Journal Title
American journal of respiratory cell and molecular biology
ISSN
1044-15491535-4989
Abstract
Pim kinases are a family of serine/threonine kinases whose activity can be induced by cytokines involved in allergy and asthma. These kinases play a role in cell survival and proliferation, but have not been examined, to the best of our knowledge, in the development of allergic disease. This study sought to determine the role of Pim1 kinase in the development of allergic airway responses. Mice were sensitized and challenged with antigen (primary challenge), or were sensitized, challenged, and rechallenged with allergen in a secondary model. To assess the role of Pim1 kinase, a small molecule inhibitor was administered orally after sensitization and during the challenge phase. Airway responsiveness to inhaled methacholine, airway and lung inflammation, cell composition, and cytokine concentrations were assessed. Lung Pim1 kinase concentrations were increased after ovalbumin sensitization and challenge. In the primary allergen challenge model, treatment with the Pim1 kinase inhibitor after sensitization and during airway challenges prevented the development of airway hyperresponsiveness, eosinophilic airway inflammation, and goblet cell metaplasia, and increased Th2 cytokine concentrations in bronchoalveolar fluid in a dose-dependent manner. These effects were also demonstrated after a secondary allergen challenge, where lung allergic disease was established before treatment. After treatment with the inhibitor, a significant reduction was evident in the number of CD4(+) and CD8(+) T cells and concentrations of cytokines in the airways. The inhibition of Pim1 kinase was effective in preventing the development of airway hyperresponsiveness, airway inflammation, and cytokine production in allergen-sensitized and allergen-challenged mice. These data identify the important role of Pim1 kinase in the full development of allergen-induced airway responses.
MeSH terms
Allergens/*immunologyAnimalsBronchoalveolar Lavage FluidCD4-Positive T-Lymphocytes/drug effectsCD8-Positive T-Lymphocytes/drug effectsCytokines/metabolismDisease Models, AnimalEnzyme Inhibitors/*pharmacologyFemaleGoblet Cells/drug effectsHypersensitivity/*immunologyInflammation/*immunologyLung/drug effects/pathologyMethacholine Chloride/pharmacologyMiceMice, Inbred BALB COvalbumin/immunology/pharmacologyPneumonia/immunology/pathologyProto-Oncogene Proteins c-pim-1/antagonists & inhibitors/*metabolismRespiratory Hypersensitivity/*immunology/prevention & control
DOI
10.1165/rcmb.2011-0190OC
PMID
22074702
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Allergy
AJOU Authors
신, 유섭
Full Text Link
Files in This Item:
fulltext not available.txtDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse